EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AGER-1 Long Non-Coding RNA Levels Correlate with the Expression of the Advanced Glycosylation End-Product Receptor, a Regulator of the Inflammatory Response in Visceral Adipose Tissue of Women with Obesity and Type 2 Diabetes Mellitus

Klaudia Gutowska, Krzysztof Koźniewski, Michał Wąsowski iD, Marta Izabela Jonas, Zbigniew Bartoszewicz, Wojciech Lisik iD, Maurycy Jonas, Artur Binda, Paweł Jaworski, Wiesław Tarnowski, Bartłomiej Noszczyk, Monika Puzianowska-Kuźnicka iD und 2 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242417447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Klaudia Gutowska und 13 weiteren Autor:innen. Beteiligte Einrichtung: II Department of Obstetrics and Gynecology, Warsaw Medical University, 00-315 Warsaw, Poland. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, National Science Centre Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The advanced glycosylation end-product receptor (AGER) is involved in the development of metabolic inflammation and related complications in type 2 diabetes mellitus (T2DM). Tissue expression of the AGER gene (AGER) is regulated by epigenetic mediators, including a long non-coding RNA AGER-1 (lncAGER-1). This study aimed to investigate whether human obesity and T2DM are associated with an altered expression of AGER and lncAGER-1 in adipose tissue and, if so, whether these changes affect the local inflammatory milieu. The expression of genes encoding AGER, selected adipokines, and lncAGER-1 was assessed using real-time PCR in visceral (VAT) and subcutaneous (SAT) adipose tissue. VAT and SAT samples were obtained from 62 obese (BMI > 40 kg/m2; N = 24 diabetic) and 20 normal weight (BMI = 20–24.9 kg/m2) women, while a further 15 SAT samples were obtained from patients who were 18 to 24 months post-bariatric surgery. Tissue concentrations of adipokines were measured at the protein level using an ELISA-based method. Obesity was associated with increased AGER mRNA levels in SAT compared to normal weight status (p = 0.04) and surgical weight loss led to their significant decrease compared to pre-surgery levels (p = 0.01). Stratification by diabetic status revealed that AGER mRNA levels in VAT were higher in diabetic compared to non-diabetic women (p = 0.018). Elevated AGER mRNA levels in VAT of obese diabetic patients correlated with lncAGER-1 (p = 0.04, rs = 0.487) and with interleukin 1β (p = 0.008, rs = 0.525) and resistin (p = 0.004, rs = 0.6) mRNA concentrations. In conclusion, obesity in women is associated with increased expression of AGER in SAT, while T2DM is associated with increased AGER mRNA levels and pro-inflammatory adipokines in VAT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingDiabetes Mellitus, Type 2HumansFemaleIntra-Abdominal FatObesityAdipose TissueAdipokinesGlycation End Products, AdvancedRNA, MessengerSubcutaneous Fat

Stichwörter der Autor:innen

adipose tissueadvanced glycosylation end-product receptor (AGER)advanced glycosylation end-products (AGEs)long non-coding RNA (lncRNA)metabolic inflammationobesitytype 2 diabetes mellitus (T2DM)

Substanzen

RNA, Long NoncodingAdipokinesGlycation End Products, AdvancedRNA, Messenger

Autor:innen und Institutionen

  • II Department of Obstetrics and Gynecology, Warsaw Medical University, 00-315 Warsaw, Poland.
  • Department of Human Epigenetics, Mossakowski Medical Research Centre, Polish Academy of Sciences, 02-106 Warsaw, Poland.
  • Department of General Medicine and Geriatric Cardiology, Medical Centre of Postgraduate Education, 00-401 Warsaw, Poland.
  • Department of Internal Medicine and Endocrinology, The Medical University of Warsaw, 02- 097 Warsaw, Poland.
  • Department of General and Transplantation Surgery, The Medical University of Warsaw, 02-005 Warsaw, Poland.
  • Department of General Surgery, Barska Hospital, 02-315 Warsaw, Poland.

ORCID-Profile: Michał Wąsowski, Wojciech Lisik, Monika Puzianowska-Kuźnicka, Alina Kuryłowicz

Förderung

  • National Science Center
  • National Science Centre Poland

Zitieren

APA

Gutowska, K., Koźniewski, K., Wąsowski, M., Jonas, M. I., Bartoszewicz, Z., Lisik, W., Jonas, M., Binda, A., Jaworski, P., Tarnowski, W., Noszczyk, B., Puzianowska-Kuźnicka, M., Czajkowski, K., & Kuryłowicz, A. (2023). AGER-1 Long Non-Coding RNA Levels Correlate with the Expression of the Advanced Glycosylation End-Product Receptor, a Regulator of the Inflammatory Response in Visceral Adipose Tissue of Women with Obesity and Type 2 Diabetes Mellitus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417447

Vancouver

Gutowska K, Koźniewski K, Wąsowski M, Jonas MI, Bartoszewicz Z, Lisik W, et al. AGER-1 Long Non-Coding RNA Levels Correlate with the Expression of the Advanced Glycosylation End-Product Receptor, a Regulator of the Inflammatory Response in Visceral Adipose Tissue of Women with Obesity and Type 2 Diabetes Mellitus. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417447

BibTeX
@article{Gutowska2023,
  author = {Gutowska, Klaudia and Koźniewski, Krzysztof and Wąsowski, Michał and Jonas, Marta Izabela and Bartoszewicz, Zbigniew and Lisik, Wojciech and Jonas, Maurycy and Binda, Artur and Jaworski, Paweł and Tarnowski, Wiesław and Noszczyk, Bartłomiej and Puzianowska-Kuźnicka, Monika and Czajkowski, Krzysztof and Kuryłowicz, Alina},
  title = {AGER-1 Long Non-Coding RNA Levels Correlate with the Expression of the Advanced Glycosylation End-Product Receptor, a Regulator of the Inflammatory Response in Visceral Adipose Tissue of Women with Obesity and Type 2 Diabetes Mellitus},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242417447}
}
Kostenlos starten →